Related references
Note: Only part of the references are listed.Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins
Irina Debnath et al.
INTERNATIONAL IMMUNOLOGY (2013)
BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia
S. Agatheeswaran et al.
LEUKEMIA (2013)
Refining the phenotype associated with MEF2C point mutations
Thierry Bienvenu et al.
NEUROGENETICS (2013)
Functional Gene Expression Analysis of Tissue-Specific Isoforms of Mef2c
Yoshiharu Sekiyama et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation in Drosophila
S. K. Pallavi et al.
EMBO JOURNAL (2012)
Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells
Sarah F. Andrews et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Notch3 and Mef2c Proteins Are Mutually Antagonistic via Mkp1 Protein and miR-1/206 MicroRNAs in Differentiating Myoblasts
Jeffrey Gagan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Mef2c deletion in osteocytes results in increased bone mass
Ina Kramer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
A. Ptasinska et al.
LEUKEMIA (2012)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
In Vivo Analysis of MEF2 Transcription Factors in Synapse Regulation and Neuronal Survival
M. Waseem Akhtar et al.
PLOS ONE (2012)
Clinically Relevant Single Gene or Intragenic Deletions Encompassing Critical Neurodevelopmental Genes in Patients With Developmental Delay, Mental Retardation, and/or Autism Spectrum Disorders
Fady M. Mikhail et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia
Irene Homminga et al.
CANCER CELL (2011)
The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10
Pooja Agarwal et al.
DEVELOPMENT (2011)
PC4/Tis7/IFRD1 Stimulates Skeletal Muscle Regeneration and Is Involved in Myoblast Differentiation as a Regulator of MyoD and NF-κB
Laura Micheli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
ETV6 mutations in early immature human T cell leukemias
Pieter Van Vlierberghe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model
Eun-Gyung Cho et al.
PLOS ONE (2011)
The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome
M. Zweier et al.
MOLECULAR SYNDROMOLOGY (2011)
Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia
Jules P. P. Meijerink
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Alternative splicing of Mef2c promoted by Fox-1 during neural differentiation in P19 cells
Nor Hakimah Ab Hakim et al.
GENES TO CELLS (2010)
MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations
N. Le Meur et al.
JOURNAL OF MEDICAL GENETICS (2010)
HOXA9 is required for survival in human MLL-rearranged acute leukemias
Joerg Faber et al.
BLOOD (2009)
Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis
Christos Gekas et al.
BLOOD (2009)
Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C
Maike Schwieger et al.
BLOOD (2009)
Transcriptional Mechanisms by the Coregulator MAML1
M. Just Ribeiro et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2009)
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes
Angela Nebbioso et al.
EMBO REPORTS (2009)
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Elaine Coustan-Smith et al.
LANCET ONCOLOGY (2009)
Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C
Zhen-Xing Ji et al.
MOLECULAR GENETICS AND GENOMICS (2009)
Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c
Sandra Stehling-Sun et al.
NATURE IMMUNOLOGY (2009)
The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate
Andrea Schueler et al.
BLOOD (2008)
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia
Pieter Van Vlierberghe et al.
BLOOD (2008)
Cooperative Interaction of Nkx2.5 and Mef2c Transcription Factors During Heart Development
Joshua W. Vincentz et al.
DEVELOPMENTAL DYNAMICS (2008)
Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells
Zhen Li et al.
JOURNAL OF NEUROSCIENCE (2008)
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223
Jonathan B. Johnnidis et al.
NATURE (2008)
Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation
Peter R. Wilker et al.
NATURE IMMUNOLOGY (2008)
Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways
A. S. McElhinny et al.
ONCOGENE (2008)
Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo
Hao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function
Ana C. Barbosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A p38 MAPK-MEF2C pathway regulates B-cell proliferation
Dustin Khiem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Competition and collaboration: GATA-3, PU.1, and Notch signaling in early T-cell fate determination
Ellen V. Rothenberg et al.
SEMINARS IN IMMUNOLOGY (2008)
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines
S. Nagel et al.
LEUKEMIA (2008)
Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia
V. Prima et al.
LEUKEMIA (2007)
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein
Francesco Fazi et al.
CANCER CELL (2007)
The transcription factor MEF2C is required for craniofacial development
Michael P. Verzi et al.
DEVELOPMENTAL CELL (2007)
MEF2C transcription factor controls chondrocyte hypertrophy and bone development
Michael A. Arnold et al.
DEVELOPMENTAL CELL (2007)
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2
Serge Gregoire et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis
HX Shen et al.
GENES & DEVELOPMENT (2006)
The calcineurin phosphatase complex modulates immunogenic B cell responses
MM Winslow et al.
IMMUNITY (2006)
A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis
F Fazi et al.
CELL (2005)
Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis
Y Du et al.
BLOOD (2005)
Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses
LH Vong et al.
GENESIS (2005)
Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain
BM Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
A Dakic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia
V Prima et al.
LEUKEMIA (2005)
Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation
KW Ma et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C
L Micheli et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phosphorylation and alternative Pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity
BM Zhu et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13)
Y Yuki et al.
CANCER SCIENCE (2004)
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
F Rosenbauer et al.
NATURE GENETICS (2004)
Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBP ratio and granulocyte colony-stimulating factor
R Dahl et al.
NATURE IMMUNOLOGY (2003)
Thymopoiesis independent of common lymphoid progenitors
D Allman et al.
NATURE IMMUNOLOGY (2003)
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia
RK Vangala et al.
BLOOD (2003)
A dynamic role for HDAC7 in MEF2-mediated muscle differentiation
U Dressel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
TA McKinsey et al.
NATURE (2000)
Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2
HD Youn et al.
IMMUNITY (2000)
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases
JR Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)